Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-18-003268
Filing Date
2018-01-23
Accepted
2018-01-23 15:24:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tv483738_sc13g.htm SC 13G 34291
  Complete submission text file 0001144204-18-003268.txt   35630
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Subject) CIK: 0000887151 (see all company filings)

EIN.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42745 | Film No.: 18542222
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 PALM COURT SEWALLS POINT FL 34996
Business Address
SUBIN NEIL S (Filed by) CIK: 0001201333 (see all company filings)

Type: SC 13G